A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Thursday 10 December 2009

Munich conference to include SPCs, Paedodata

"Biotech & Pharmaceutical Patenting" is the title of a forthcoming conference, to be held at the Hilton Munich Park, Germany, on 7 and 18 February next year. The programme contains a session under the heading 'Patent Term Extensions and Paediatric Data Exclusivity', a 45-minute slot on the first day in which the speakers are Dr Frank Burkert (Bayer Healthcare) and Bert Oosting (Lovells, The Netherlands). The seven bullet-pointed topics include the ever-popular negative-term issue, post-Losartan paediatric data esclusivity and the impact of the ECJ's ruling in Case C-482/07 AHP (noted by the SPC Blog here).

Further information concerning the conference programme, as well as bookings, can be obtained from the conference website here.

No comments: